ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 780

$1.21M Total Retail Price of All Prescriptions

Rank: 33 out of 780

746 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 746 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 746 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 13,131 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,242 525 S3 1 1
ATORVASTATIN CALCIUM 792 545 2 12
AMLODIPINE BESYLATE 680 451 3 4
LEVOTHYROXINE SODIUM 551 411 4 5
CARVEDILOL 510 380 5 14
PRAVASTATIN SODIUM 500 339 6 9
OMEPRAZOLE 484 291 7 3
FUROSEMIDE 452 286 8 7
SIMVASTATIN 442 352 9 2
BENAZEPRIL HCL 360 264 10 59
ZOLPIDEM TARTRATE 341 214 11 17
POTASSIUM CHLORIDE 324 187 12 11
QUINAPRIL HCL 312 243 13 113
METFORMIN HCL 290 171 14 8
AMLODIPINE BESYLATE-BENAZEPRIL 260 167 15 50
PANTOPRAZOLE SODIUM 255 156 16 25
LISINOPRIL 246 143 17 6
LABETALOL HCL 242 146 18 159
METFORMIN HCL ER 229 97 19 43
LOSARTAN POTASSIUM 220 151 20 18
GABAPENTIN 218 152 21 13
HYDROCHLOROTHIAZIDE 210 112 22 10
MELOXICAM 199 111 23 16
CLOPIDOGREL 199 135 23 34
CLONIDINE HCL 196 78 25 28
NEXIUM 194 78 26 22
BISOPROLOL FUMARATE 192 143 27 143
CITALOPRAM HBR 182 90 28 23
ALLOPURINOL 177 114 29 29
TRAZODONE HCL 172 115 30 35
FENOFIBRATE 167 116 31 63
AZITHROMYCIN 158 106 32 38
WARFARIN SODIUM 155 127 33 24
CARISOPRODOL 152 22 R 34 67
GLIPIZIDE 149 107 35 74
DIOVAN 147 100 36 55
TAMSULOSIN HCL 146 120 37 36
RAMIPRIL 142 111 38 70
KLOR-CON M20 138 80 39 57
CRESTOR 132 62 40 32
DIOVAN HCT 130 105 41 75
VERAPAMIL ER 128 83 42 78
METOPROLOL TARTRATE 123 69 43 19
METOPROLOL SUCCINATE 121 94 44 20
TRAMADOL HCL 115 48 45 15
SERTRALINE HCL 112 90 46 27
LYRICA 111 75 47 52
PLAVIX 106 85 48 45
CIPROFLOXACIN HCL 106 92 48 49
PROMETHAZINE HCL 105 17 R 50 66
OXYCONTIN 104 38 S2 51 165
CYCLOBENZAPRINE HCL 103 20 R 52 42
SPIRONOLACTONE 102 58 53 53
CYMBALTA 99 54 54 51
TRIAMTERENE-HCTZ 97 59 55 37
LIPITOR 93 68 56 175
PREDNISONE 92 55 57 40
FLUOXETINE HCL 92 44 57 65
AMILORIDE-HYDROCHLOROTHIAZIDE 91 40 59 309
LOSARTAN-HYDROCHLOROTHIAZIDE 89 40 60 33
OXYCODONE HCL 89 57 S2 60 123
ATENOLOL 88 66 62 21
FLUTICASONE PROPIONATE 87 58 63 41
CELEBREX 86 59 64 89
METHOCARBAMOL 84 44 R 65 84
RANITIDINE HCL 84 28 65 39
HYDRALAZINE HCL 81 50 67 54
SINGULAIR 78 48 68 73
SYNTHROID 77 59 69 77
DOXYCYCLINE HYCLATE 76 43 70 103
BYSTOLIC 75 53 71 118
ESCITALOPRAM OXALATE 73 58 72 61
ENDOCET 72 13 S2 73 129
DIGOXIN 71 40 74 56
OXYCODONE HCL-ACETAMINOPHEN 70 33 S2 75 146
CHLORTHALIDONE 69 60 76 142
ADVAIR DISKUS 68 44 77 68
TIZANIDINE HCL 67 30 78 82
TRICOR 66 59 79 152
PROAIR HFA 65 22 80 62
AMLODIPINE-ATORVASTATIN 63 51 81 411
PAROXETINE HCL 63 53 81 69
METHYLPREDNISOLONE 62 33 83 92
JANUVIA 61 50 84 85
NAMENDA 60 60 85 46
ZETIA 59 34 86 94
AMITRIPTYLINE HCL 58 40 R 87 48
CLOTRIMAZOLE-BETAMETHASONE 58 27 87 166
NIASPAN 57 51 89 167
BUMETANIDE 57 39 89 96
MONTELUKAST SODIUM 57 33 89 120
SPIRONOLACTONE-HCTZ 56 49 92 204
ALENDRONATE SODIUM 56 56 92 44
NIFEDIPINE ER 55 38 94 115
CEPHALEXIN 54 35 95 105
MECLIZINE HCL 52 44 96 83
DONEPEZIL HCL 51 46 97 31
IBUPROFEN 51 17 97 93
GLIMEPIRIDE 50 34 99 30
VESICARE 50 40 99 186
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 45 99 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.